ABBV Beats on Q3 Earnings & Sales, Stock Rises on Raised '26 EPS ViewZacks Investment Research • 10/30/26
$250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in Dividends24/7 Wall Street • 10/30/26
AbbVie's Earnings Double As Immunology Powerhouse Skyrizi Beats AgainInvestors Business Daily • 10/30/26
Retire on Dividends: 5 High-Yield Stocks Boomers Are Buying and Holding Forever24/7 Wall Street • 10/28/26
4 Arthritis Drug Stocks Investors Should Monitor for Growth PotentialZacks Investment Research • 10/27/26
AbbVie: Analyzing Performance, Pipeline, And Pricing Ahead Of Q3 (Strong Buy)Seeking Alpha • 10/27/26
Allergan Aesthetics Announces 2026 Grant Recipients of The Confidence Collective, Funded by BOTOX® Cosmetic (onabotulinumtoxinA)PRNewsWire • 10/27/26
AbbVie Submits Biologics License Application (BLA) for Etentamig to U.S. FDA for Adults Living With Relapsed/Refractory Multiple MyelomaPRNewsWire • 10/27/26
Allergan Aesthetics Celebrates Eight Years of Engaging Girls in STEM Through Continued Partnership with Girls Inc.PRNewsWire • 10/26/26